hpv16 positive carcinoma control serological test

摘要

The present invention relates to a method for the therapeutic control of hpv16 positive carcinoma, an antibody for use in the corresponding diagnostic method, as well as a test to perform the method. In particular, the present invention relates to a serological method for monitoring the development of the amount of antibodies in samples that were obtained from a patient before and after treatment of a hpv16 positive carcinoma for a predetermined period of time. furthermore, the invention provides an immunological test in the form of a kit, with which the method according to the invention may be performed.